Colorectal Cancer Alliance announces up to $775,000 in available research funding

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Colorectal Cancer Alliance announced up to $775,000 in available funding for research in young-onset colorectal cancer, rectal cancer, and colorectal cancer prevention. The Alliance will award up to five research grants for work that will advance its mission of ending colorectal cancer within our lifetime.

The grants will be awarded through the Chris4Life Research Program, which was established in 2010 to honor the late Christine Sapienza and all who are affected by colorectal cancer. The Alliance is committed to investing $10 million in critical research by 2021, including $3 million specifically to young-onset colorectal cancer research.

Additional funding for rectal cancer research may become available pending further financial support.

Proposals will be accepted now through October 1 online.

Grant recipients will be notified in December, with funding to commence in January 2019. More information about each grant:


Young-onset colorectal cancer research grants

Up to three 2-year grants in the amount of $125,000 each will be awarded to support research in young-onset colorectal cancer. The focus of research could be, but is not limited to, the following:

  • The risk factors and causes associated with the rise in young-onset colorectal cancer.

  • Prevention and early detection strategies.

  • Better mechanisms for increasing long-term survival rates.

  • The psychosocial impacts of young-onset colorectal cancer and the overall social influence on daily survivorship.


Rectal cancer research grant

One 2-year grant in the amount of $250,000 will be awarded to support research on rectal cancer research. The focus of research could be, but is not limited to, the following:

  • The risk factors and causes associated with the rise in rectal cancer in adults 55 and younger.

  • Prevention and early detection strategies.

  • Better mechanisms for increasing long-term survival rates.

  • The psychosocial impacts of rectal cancer and the overall social influence on daily survivorship.

  • The exploration and recommendations for improvements in the number of cases associated with Low Anterior Resection Syndrome.


Prevention research grant

One grant in the amount of $150,000 will be awarded over a two-year period to support the work of a researcher while working on mentored, colorectal cancer prevention research. The focus of research could be, but is not limited to, the following:

  • Improving colorectal cancer screening compliance.

  • Improving patient understanding of colonoscopy results, especially implications for diagnosis of advanced adenoma as it pertains to personal and family risk.

  • Preventing colorectal cancer and/or advanced adenoma recurrence.

The goal of the Colorectal Cancer Alliance’s research program is to provide funding for innovative projects expected to lead to future funding from other peer-reviewed sources.

Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login